For indications other than weight loss, Health Net follows FDA-approved labeling for BMI requirements
Learn about our quality process Related products Cagrilintide/GLP-1 Blend 5+5mg Summary Description: Cagrilintide and semaglutide are two structurally unrelated peptide-based therapeutic agents (an amylin analogue and a glucagon-like peptide-1 (GLP-1) receptor agonist, respectively)
It can be taken in conjunction with an appetite suppressant like phentermine or phendimetrazine
For persistent constipation, prescription-strength options like linaclotide or lubiprostone may be necessary when over-the-counter solutions are insufficient
Obes Res Clin Pract (2019) 13(4):38590
However, highly effective therapies like Retatrutide could mean that more patients delay insulin initiation, require lower doses, or avoid complex insulin regimens for longer periods